1. Home
  2. TACT vs IXHL Comparison

TACT vs IXHL Comparison

Compare TACT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$4.47

Market Cap

46.1M

Sector

Technology

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.40

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TACT
IXHL
Founded
1996
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Computer peripheral equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
46.1M
49.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
TACT
IXHL
Price
$4.47
$0.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
49.1K
10.4M
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,258,000.00
$12,000.00
Revenue This Year
$21.67
$1,188.37
Revenue Next Year
$7.63
$3,569.49
P/E Ratio
N/A
N/A
Revenue Growth
8.27
N/A
52 Week Low
$3.12
$0.08
52 Week High
$5.70
$2.25

Technical Indicators

Market Signals
Indicator
TACT
IXHL
Relative Strength Index (RSI) 51.95 57.52
Support Level $4.30 $0.35
Resistance Level $4.75 $0.37
Average True Range (ATR) 0.25 0.02
MACD 0.05 0.01
Stochastic Oscillator 64.71 96.49

Price Performance

Historical Comparison
TACT
IXHL

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: